+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Europe Fibromyalgia Market and Competitive Landscape - 2020

  • ID: 5023518
  • Report
  • April 2020
  • Region: Europe
  • Fore Pharma
1 of 2
The research report Europe Fibromyalgia Market and Competitive Landscape - 2020, provides comprehensive insights into the Fibromyalgia pipeline, epidemiology, market valuations, drug sales, market forecast, drug forecasts, and market shares. This research analyzes and forecasts the Fibromyalgia market size and drug sales. It also provides insights into Fibromyalgia epidemiology and late stage pipeline.

This research covers the following: Fibromyalgia treatment options, Fibromyalgia late stage clinical trials pipeline, Fibromyalgia prevalence by countries, Fibromyalgia market size and forecast by countries, key market events and trends, drug sales and forecast by countries, and market shares by countries. The research scope includes the countries Germany, France, Italy, Spain, UK, Europe (EU5 Countries).

Research Scope:
  • Countries: Germany, France, Italy, Spain, UK, Europe
  • Fibromyalgia pipeline: Find out drugs in clinical trials for the treatment of Fibromyalgia by development phase 3, phase 2, and phase 1, by pharmacological class and company
  • Fibromyalgia epidemiology: Find out the number of patients diagnosed (prevalence) with Fibromyalgia by countries
  • Fibromyalgia drugs: Identify key drugs marketed and prescribed for Fibromyalgia in the US, including trade name, molecule name, and company
  • Fibromyalgia drugs sales: Find out the sales value for Fibromyalgia drugs by countries
  • Fibromyalgia market valuations: Find out the market size for Fibromyalgia drugs in 2019 by countries. Find out how the market advanced from 2016 and forecast to 2024
  • Fibromyalgia drugs market share: Find out the market shares for key drugs by countries
Benefits of this Research:
  • Evaluate commercial market opportunities for Fibromyalgia drugs
  • Synthesize insights for business development & licensing
  • Track market size, competitor drug sales, market shares in the Fibromyalgia market
  • Develop in-depth knowledge of competition and markets
  • Analyze Fibromyalgia drug sales data to update your brand planning trackers
  • Develop tactics and strategies to take advantage of opportunities in the market
  • Track Market Events and Trends and analyze key events in the Fibromyalgia market
  • Develop forecast models, healthcare frameworks, or economic models
  • Answer key business questions; supports decision making in R&D to long term marketing strategies
Note: Product cover images may vary from those shown
2 of 2
1. Fibromyalgia Treatment Options

2. Fibromyalgia Pipeline Insights
2.1. Fibromyalgia Phase 3 Clinical Trials
2.2. Fibromyalgia Phase 2 Clinical Trials
2.3. Fibromyalgia Phase 1 Clinical Trials

3. Fibromyalgia Epidemiology Analysis by Countries

4. Germany Fibromyalgia Market Insights
4.1. Marketed Drugs for Fibromyalgia in Germany
4.2. Germany Fibromyalgia Market Size & Forecast
4.3. Germany Fibromyalgia Drugs Sales Forecast
4.4. Germany Fibromyalgia Market Share Analysis

5. France Fibromyalgia Market Insights
5.1. Marketed Drugs for Fibromyalgia in France
5.2. France Fibromyalgia Market Size & Forecast
5.3. France Fibromyalgia Product Sales Forecast
5.4. France Fibromyalgia Market Share Analysis

6. Italy Fibromyalgia Market Insights
6.1. Marketed Drugs for Fibromyalgia in Italy
6.2. Italy Fibromyalgia Market Size & Forecast
6.3. Italy Fibromyalgia Product Sales Forecast
6.4. Italy Fibromyalgia Market Share Analysis

7. Spain Fibromyalgia Market Insights
7.1. Marketed Drugs for Fibromyalgia in Spain
7.2. Spain Fibromyalgia Market Size & Forecast
7.3. Spain Fibromyalgia Product Sales Forecast
7.4. Spain Fibromyalgia Market Share Analysis

8. UK Fibromyalgia Market Insights
8.1. Marketed Drugs for Fibromyalgia in UK
8.2. UK Fibromyalgia Market Size & Forecast
8.3. UK Fibromyalgia Product Sales Forecast
8.4. UK Fibromyalgia Market Share Analysis

9. Europe Fibromyalgia Market Insights
9.1. Europe Fibromyalgia Market Size & Forecast
9.2. Europe Fibromyalgia Product Sales Forecast
9.3. Europe Fibromyalgia Market Share Analysis

10. Research Methodology

List of Tables
Table 1: Fibromyalgia Phase 3 Clinical Trials, Global, 2020
Table 2: Fibromyalgia Phase 2 Clinical Trials, Global, 2020
Table 3: Fibromyalgia Phase 1 Clinical Trials, Global, 2020
Table 4: Fibromyalgia Prevalence by Countries, 2016 - 2024
Table 5: Marketed Drugs for Fibromyalgia in Germany, 2019
Table 6: Germany Fibromyalgia Market Size & Forecast ($mn), 2016 - 2024
Table 7: Germany Fibromyalgia Product Sales ($mn), 2016 - 2024
Table 8: Germany Fibromyalgia Market Events and Trends, 2016 - 2024
Table 9: Marketed Drugs for Fibromyalgia in France, 2019
Table 10: France Fibromyalgia Market Size & Forecast ($mn), 2016 - 2024
Table 11: France Fibromyalgia Product Sales ($mn), 2016 - 2024
Table 12: France Fibromyalgia Market Events and Trends, 2016 - 2024
Table 13: Marketed Drugs for Fibromyalgia in Italy, 2019
Table 14: Italy Fibromyalgia Market Size & Forecast ($mn), 2016 - 2024
Table 15: Italy Fibromyalgia Product Sales ($mn), 2016 - 2024
Table 16: Italy Fibromyalgia Market Events and Trends, 2016 - 2024
Table 17: Marketed Drugs for Fibromyalgia in Spain, 2019
Table 18: Spain Fibromyalgia Market Size & Forecast ($mn), 2016 - 2024
Table 19: Spain Fibromyalgia Product Sales ($mn), 2016 - 2024
Table 20: Spain Fibromyalgia Market Events and Trends, 2016 - 2024
Table 21: Marketed Drugs for Fibromyalgia in UK, 2019
Table 22: UK Fibromyalgia Market Size & Forecast ($mn), 2016 - 2024
Table 23: UK Fibromyalgia Product Sales ($mn), 2016 - 2024
Table 24: UK Fibromyalgia Market Events and Trends, 2016 - 2024
Table 25: Europe Fibromyalgia Market Size & Forecast ($mn), 2016 - 2024
Table 26: Europe Fibromyalgia Product Sales ($mn), 2016 - 2024

List of Figures
Figure 1: Fibromyalgia Pipeline by Phase (%), Global, 2020
Figure 2: Fibromyalgia Prevalence by Countries, 2016 - 2024
Figure 3: Germany Fibromyalgia Market Size ($mn), 2016 - 2024
Figure 4: Germany Fibromyalgia Product Sales ($mn), 2016 - 2024
Figure 5: Germany Fibromyalgia Market Share by Drugs (%), 2019
Figure 6: Germany Fibromyalgia Market - Future Market Share (%), 2024
Figure 7: France Fibromyalgia Market Size ($mn), 2016 - 2024
Figure 8: France Fibromyalgia Product Sales ($mn), 2016 - 2024
Figure 9: France Fibromyalgia Market Share by Drugs (%), 2019
Figure 10: France Fibromyalgia Market - Future Market Share (%), 2024
Figure 11: Italy Fibromyalgia Market Size ($mn), 2016 - 2024
Figure 12: Italy Fibromyalgia Product Sales ($mn), 2016 - 2024
Figure 13: Italy Fibromyalgia Market Share by Drugs (%), 2019
Figure 14: Italy Fibromyalgia Market - Future Market Share (%), 2024
Figure 15: Spain Fibromyalgia Market Size ($mn), 2016 - 2024
Figure 16: Spain Fibromyalgia Product Sales ($mn), 2016 - 2024
Figure 17: Spain Fibromyalgia Market Share by Drugs (%), 2019
Figure 18: Spain Fibromyalgia Market - Future Market Share (%), 2024
Figure 19: UK Fibromyalgia Market Size ($mn), 2016 - 2024
Figure 20: UK Fibromyalgia Product Sales ($mn), 2016 - 2024
Figure 21: UK Fibromyalgia Market Share by Drugs (%), 2019
Figure 22: UK Fibromyalgia Market - Future Market Share (%), 2024
Figure 23: Europe Fibromyalgia Market Size ($mn), 2016 - 2024
Figure 24: Europe Fibromyalgia Product Sales ($mn), 2016 - 2024
Figure 25: Europe Fibromyalgia Market Share by Drugs (%), 2019
Figure 26: Europe Fibromyalgia Market - Future Market Share (%), 2024
Note: Product cover images may vary from those shown
3 of 2

Loading
LOADING...

Adroll
adroll